Abstract
To investigate the characteristics long-Term prognostic implications (up to ∼2.2 years) of atrial fibrillation (AF) compared to sinus rhythm (SR), between acute and chronic heart failure (HF) with reduced (HFrEF < 40%), midrange (HFmrEF 40-49%), and preserved (HFpEF ≤ 50%) ejection fraction (EF). Methods and results Data from the observational, prospective, HF long-Term registry of the European Society of Cardiology were analysed. A total of 14 964 HF patients (age 66 ± 13 years, 67% male; 53% HFrEF, 21% HFmrEF, 26% HFpEF) were enrolled. The prevalence of AF was 27% in HFrEF, 29% in HFmrEF, and 39% in HFpEF. Atrial fibrillation was associated with older age, lower functional capacity, and heightened physical signs of HF. Crude rates of mortality and HF hospitalization were higher in patients with AF compared to SR, in each EF subtype. After multivariable adjustment, the hazard ratio of AF for HF hospitalizations was: 1.036 (95% CI 0.888-1.208, P = 0.652) in HFrEF, 1.430 (95% CI 1.087-1.882, P = 0.011) in HFmrEF, and 1.487 (95% CI 1.195-1.851, P < 0.001) in HFpEF; and for combined all-cause death or HF hospitalizations: 0.957 (95% CI 0.843-1.087, P = 0.502), 1.302 (95% CI 1.055-1.608, P = 0.014), and 1.365 (95% CI 1.152-1.619, P < 0.001), respectively. In patients with HFrEF, AF was not associated with worse outcomes in those presenting with either an acute or a chronic presentation of HF.
Original language | English |
---|---|
Pages (from-to) | 4277-4284 |
Number of pages | 8 |
Journal | European Heart Journal |
Volume | 39 |
Issue number | 48 |
DOIs | |
State | Published - 21 Dec 2018 |
Bibliographical note
Publisher Copyright:© Oxford University Press. All rights reserved.
Funding
1Department of Cardiology, Lady Davis Carmel Medical Center, Haifa, Israel; 2Heart and Vascular Theme, Karolinska University Hospital, Stockholm; 3Department of Medicine, Karolinska Institutet, Stockholm, Sweden; 4EURObservational Research Programme, European Society of Cardiology, Sophia-Antipolis, France; 5Heart Failure and Transplantation Clinic, University Hospital Zurich, Zurich, Switzerland; 6Unidad de Insuficiencia Cardiaca y Trasplante Cardiaco, Complexo Hospitalario Universitario A Coruna (CHUAC), INIBIC, UDC, CIBERCV, La Coruna, Spain; 7IRCCS, San Raffaele, Pisana, Rome, Italy; 8Division of Cardiology and Metabolism, Department of Cardiology (CVK), Berlin-Brandenburg Center for Regenerative Therapies (BCRT), German Centre for Cardiovascular Research (DZHK) Partner Site Berlin, Charité Universitätsmedizin Berlin, Germany; 9Department of Cardiology and Pneumology, University Medicine Göttingen (UMG), Göttingen, Germany; 10Heart Failure Unit, Department of Cardiology, Athens University Hospital Attikon, Athens, Greece; 11Department of Cardiology, Clinical Centre of Serbia, Belgrade, Serbia; 12ANMCO Research Center, Florence, Italy; 13Department of Cardiology, Hospital Regional Universitario Carlos Haya, Malaga, Spain; 14Slaskie Centrum Chorob Serca, Zabrze, Poland; 15Department of Cardiology, Faculty of Medicine of Porto University, Hospital de Sao Joao, Porto, Portugal; 16Department of Cardiovascular Medicine, Poriya Medical Center, Tiberius, Israel; and 17The Azrieli Faculty of Medicine in the Galilee, Bar-Ilan University, Safed 1311502, Israel
Funders | Funder number |
---|---|
Berlin-Brandenburg Center for Regenerative Therapies | |
Clinical Centre of Serbia, Belgrade, Serbia | |
Karolinska University Hospital | |
Deutsches Zentrum für Herz-Kreislaufforschung | |
Breast Cancer Research Trust | |
Bar-Ilan University | |
Karolinska Institutet | 7IRCCS |
Faculty of Medicine, Assiut University |
Keywords
- Ejection fraction